Is there a role for combination anti-remodelling therapy for heart failure secondary to chronic rheumatic mitral regurgitation?

INTRODUCTION: The value of combination anti-remodelling therapy for heart failure (HF) secondary to mitral regurgitation (MR) is unknown. We studied the effect of anti-remodelling therapy on clinical and echocardiographic parameters in patients with severe chronic rheumatic mitral regurgitation (CRM...

Descripción completa

Detalles Bibliográficos
Autores principales: Meel, Ruchika, Peters, Ferande, Libhaber, Elena, Essop,, Mohammed R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2017
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730678/
https://www.ncbi.nlm.nih.gov/pubmed/29144532
http://dx.doi.org/10.5830/CVJA-2016-095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730678/
https://www.ncbi.nlm.nih.gov/pubmed/29144532
http://dx.doi.org/10.5830/CVJA-2016-095

Ejemplares similares